Announcements Trials

Browse Landscape

Sponsor

Conditions

Rectal Neoplasms 2 Colorectal Neoplasms 2 Prostatic Neoplasms 1 Lung Neoplasms 1 Leukemia, Lymphocytic, Chronic, B-Cell 1 Leukemia 1 Esophageal Squamous Cell Carcinoma 1 Esophageal Neoplasms 1 Colonic Neoplasms 1 Carcinoma, Non-Small-Cell Lung 1 Carcinoma, Lobular 1 Carcinoma, Intraductal, Noninfiltrating 1 Carcinoma, Ductal, Breast 1 Breast Neoplasms 1 Breast Carcinoma In Situ 1 Adenocarcinoma Of Esophagus 1

Interventions

Magnetic Resonance Spectroscopy 10 trametinib 7 Nivolumab 7 selpercatinib 6 pembrolizumab 6 dabrafenib 6 Iodine-131 6 Specimen Handling 5 Biopsy 5 lenvatinib 4 Vemurafenib 4 Iodine-124 4 durvalumab 3 cabozantinib 3 binimetinib 3 Ipilimumab 3 Immunoglobulin G 3 Fluorodeoxyglucose F18 3 Disulfides 3 Cyclophosphamide 3 Cetuximab 3 vandetanib 2 ulixertinib 2 omipalisib 2 larotrectinib 2 defactinib 2 copanlisib 2 cemiplimab 2 anlotinib 2 Watchful Waiting 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

0 trials

Recent Start date Enrollment

Thyroid Neoplasms × Gene Expression Profiling × 1 year × Clear all

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡